More Than 1,000 Lots of Advanced Laboratory, Cell Processing and Biomanufacturing Equipment Available
Maynards Europe is offering the complete contents of the Cell for Cure advanced cell and gene therapy manufacturing facility in Paris, France, through an online auction closing on 4 November 2026.
The substantial sale comprises more than 1,000 lots from a 10,000 m² manufacturing facility incorporating six GMP production lines. With equipment dating up to 2025, the auction provides an opportunity to acquire modern laboratory, analytical, cell processing, bioreactor, cryopreservation and associated production equipment.
The range of assets extends from sophisticated analytical and flow cytometry instruments to cell expansion systems, automated cell processors, freezers, incubators, centrifuges and environmental monitoring equipment.
Key Equipment Available in the Cell for Cure Auction
Highlights of the auction include:
- More than 30 Xuri W25 cell expansion systems
- Five or more 2023 CliniMACS Prodigy closed-system cell processors
- Five or more CliniMACS Plus automated cell separators
- Four 2020 Rapid Micro Biosystems Growth Direct GD2 systems
- Three BD FACSVerse flow cytometers
- Five or more Miltenyi Biotec MACSQuant Analyzers, with equipment dating to 2023
- Bruker Alpha II FT-IR spectrometers
- Protein Simple Ella immunoassay systems
- QuantStudio 7 Flex PCR systems
- Roche LightCycler 480 II thermal block cycler
- Tecan Infinite and Spark plate readers
- Particle Metrix ZetaView nanoparticle analyser
- Eppendorf BioFlo 320 benchtop reactor
- Pall XRS 20 bioreactor
- Repligen KrosFlo KR2i protein concentration/TFF system
- Lonza 4D Nucleofector electroporation system
- More than 60 cryopreservation units, freezers and refrigerators
- More than 25 centrifuges from Eppendorf, Thermo Scientific, VWR and AWEL
- More than 40 Thermo Scientific and other laboratory incubators
- More than 100 particle and air samplers
- More than 200 single and multichannel pipette systems, including some boxed and unused equipment
- Four Qiagen QIAgility automated pipetting systems
- More than 35 Terumo, Maco and other tube welders and sealers
- Three Fedegari sterilising autoclaves, including 2020 equipment
- Flexicon PF6 peristaltic filling machines
- Aseptic Crystal M1 laser fill-sealing systems
- More than 50 safety cabinets and hoods
- More than 30 Mettler Toledo and Sartorius precision balances
- More than 12 microscopy and imaging systems from manufacturers including Invitrogen, Nikon and Leica
The sale also includes extensive general laboratory and facility equipment, including water bath systems, floor cleaning machines, Fenwick pedestrian trucks and laboratory furniture.
The breadth of the offering makes the auction particularly notable for organisations looking to establish, expand or upgrade laboratory and advanced biomanufacturing operations. The combination of complete production infrastructure and relatively recent equipment, including assets manufactured as recently as 2025, provides buyers with access to a significant concentration of specialised equipment from one facility.
The timed online auction will close from 9:00am GMT on Wednesday 4 November 2026. The assets are located in Paris, France.
About Maynards Europe
Maynards Europe forms part of the international Maynards group, which specialises in industrial auctions, asset sales, valuations and complete facility closures. The company works across a broad range of manufacturing and technology sectors, managing the sale and remarketing of individual machinery through to the contents of complete production facilities. Its international reach enables industrial assets to be marketed to buyers across Europe and worldwide.
For more information, please visit: